Robert D. Schreiber

机构：Barnes-Jewish Hospital, Washington University in St. Louis, Jewish Hospital, Parker Institute for Cancer Immunotherapy, Washington School of Psychiatry · ORCID：0000-0003-1590-2341

发表论文 710 篇 · 总被引 110459 次 · h-index 134

代表论文

• Synthetic long peptide and DNA personalized cancer vaccines induce robust neoantigen-specific T cell responses in pancreatic cancer (2026 · Science Advances)
• Personalized Neoantigen Vaccines Synergize with Immune Checkpoint Therapy and CD8-Targeted Cytokines to Control B-Cell Lymphoma (2026 · bioRxiv (Cold Spring Harbor Laboratory))
• CD4+ T Cells Play Distinct Roles during the Priming versus Effector Phases of Immune Checkpoint Therapy–Dependent Tumor Elimination by CD8+ T Cells (2026 · Cancer Immunology Research)
• pVACtools v6: A comprehensive suite for neoantigen prediction, visualization, and therapy design (2026 · arXiv (Cornell University))
• Supplementary Table S2 from IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity (2026)
• Supplementary Table S1 from IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity (2026)